About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

2016 May 19 AGM Chairman and CEO Addresses

May 19, 2016

Click here to read more

Post navigation

Retirement of Non-Executive Director

Appointment of Non-Executive Director

Related Posts

Phosphagenics’ PHN Trial Completes Enrolment and Dosing

December 17, 2015

Phosphagenics Licencing Agreement Update

September 10, 2018

Dosing Commences for CBD Topical Osteoarthritis Study

March 1, 2022March 2, 2022

Recent Posts

Recruitent recommences for phase III insomnia trial
August 31, 2026
Euroz Hartleys | Successful Phase 3 Interim Results
July 8, 2026
Avecho Phase III insomnia trial advances following positive interim analysis
June 24, 2026

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.